United Therapeutics (UTHR) June volatility elevated into data releases

United Therapeutics (Nasdaq: UTHR) is recently trading at $67.23. Remodulin Phase 3 Freedom-M data is expected in June and Freedom-C is expected in December. June put option implied volatility is at 65, August is at 59, November is at 61; compared to its six-month average of 50 according to Track Data.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Norwegian Cruise Line (NCLH) call put ratio 1 call to 2.4 puts amid price movement
• Carnival Corp. (CCL) call put ratio 1 call to 1.1 puts amid price movement